hsa-mir-4505: Hsa-mir-4505 is a microRNA that has been studied in various contexts, including infectious diseases, cardiovascular events, and cancer. It has been shown to be involved in the regulation of target genes such as C8orf37, EFNA5, HOOK3, MYOZ3, PCP4L1, SLC2A3, SNRPA1, IQCG, PLAG1, and POLI [PMC9738797]. In the context of infectious diseases and HIV infection specifically, hsa-mir-4505 has been found to be downregulated in different comparisons such as VP vs HIV-, EC vs HIV-, and ART vs HIV- [PMC4865051]. In cardiovascular events patients and non-small cell lung cancer (NSCLC), hsa-mir-4505 was found to be downregulated [PMC9827273] [PMC6830863]. However, the role of hsa-mir-4505 in cardiovascular risk or disease is not yet known [PMC9827273]. In NSCLC specifically hsa-mir-4505 was found to be regulated by lncRNA DGCR5 [PMC6830863]. Hsa-mir-4505 has also been shown to target S100A12 and regulate heat shock protein A12B (HSPA12B) in vascular endothelial cell injury induced by lipopolysaccharide (LPS) [PMC9436632]. Furthermore a miRNA-mRNA regulatory network was constructed that included hsa-mir-4505 targeting RBM28 mRNA among others [PMC9532133]. However the expression levels of hsa-mir-4505 were not proven to be significant in some studies [PMC4416288]